Lysophosphatidic Acid and its Receptors LPA and LPA Mediate Paclitaxel-Induced Neuropathic Pain in Mice
Background: Paclitaxel, which is widely used for the treatment of solid tumors, causes neuropathic pain via poorly understood mechanisms. Previously, we have demonstrated that lysophosphatidic acid (LPA) and its receptors (LPA 1 and LPA 3 ) are required for the initiation of peripheral nerve injury-...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2014-11-01
|
| Schriftenreihe: | Molecular Pain |
| Online-Zugang: | https://doi.org/10.1186/1744-8069-10-71 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|